In accordance with the agreement, teams of ChemDiv and Schering Plough scientists will work closely to develop exclusive small molecule libraries enhancing Schering Plough’s global drug discovery effort.
Nikolay Savchuk, president and CEO of ChemDiv, said: “ChemDiv is excited to be working with Schering Plough a pioneer of pharmaceutical industry that is working to improve people’s health and extend lives. Their decision to select ChemDiv as their drug discovery partner underscores the quality of our work, the innovation we bring to our partners and our solid reputation for success in this field.”